BENFOTHIAMINE ADMINISTRATION IN PATIENTS WITH DILATED CARDIOMYOPATHY AND ADVANCED HEART FAILURE WITH CHRONIC DIURETIC TREATMENT

Authors

  • Dana-Adriana ILUȚIU-VARVARA Facultatea de Instalaţii, Universitatea Tehnică, Cluj-Napoca, Romania. Email: dana.adriana.varvara@insta.utcluj.ro. https://orcid.org/0000-0003-1141-5570
  • Dan RĂDULESCU Universitatea de Medicină şi Farmacie Iuliu Hațieganu, Facultatea de Medicină, Cluj-Napoca, Romania. Email: dan.radulescu@umfcluj.ro.
  • Valer Ioan DONCA Universitatea de Medicină şi Farmacie Iuliu Hațieganu, Facultatea de Medicină, Cluj-Napoca, Romania. Email: ioan.donca@umfcluj.ro. https://orcid.org/0000-0003-0231-2131

DOI:

https://doi.org/10.24193/subbchem.2017.1.20

Keywords:

benfothiamine, cardiovascular diseases, cardiomyopathy, diuretic treatment, heart failure, thiamine

Abstract

It is well known that long term administration of high dose loop diuretics in patients with heart failure, may in some cases aggravate the cardiac failure symptoms. Part of this effect may be due to thiamine depletion secondary to diuretics use. The aim of our present study was to assess whether administration of benfothiamine in patients with advanced congestive cardiac failure treated on long term with high dose loop diuretics, can prevent the alteration of heart failure.

References

D. Loew, International Journal of Clinical Pharmacology and Therapeutics, 1996, 34, 47.

Howard Smithline, M. Donnino, D.J. Greenblatt, BMC Clinical Pharmacology, 2012, 12, 4.

K.T. Weber, Journal of the American College of Cardiology, 2004, 44, 1308.

J. Lu, E.L. Frank, Clinical Chemistry, 2008, 54, 901.

D. Leslie, M. Gheorghiade, American Heart Journal, 1996, 131, 1.

Shimon, S. Almog, Z. Vered, H. Seligmann, M. Shefi, E. Peleg, American Journal of Medicine, 1995, 98, 485.

M. Fujiwara, H. Watanabe, K. Matsui, Journal of Biochemistry, 1954, 41, 29.

P. Balakumar, A. Rohilla, P. Krishan, P. Solairaj, A. Thangathirupathi, Pharmacological Research, 2010, 61, 482.

M.L. Volvert, S. Seyen, M. Piette, B. Evrard, M. Gangolf, J.C. Plumier, L. Bettendorff, BMC Clinical Pharmacology, 2008, 8, 10.

Stirban, M. Negrean, B. Stratmann, Diabetes Care, 2006, 29, 2064.

Stirban, M. Negrean, B. Stratmann, Diabetes Care, 2007, 30, 10.

D.A. Fraser, N.P. Hessvik, N. Nikolić, V. Aas, K.F. Hanssen, S.K. Bøhn, G.H. Thoresen, A.C. Rustan, Genes & Nutrition, 2012, 7, 459.

Greb, R. Bitsch, International Journal of Clinical Pharmacology and Therapeutics, 1998, 36, 216.

D. Lonsdale, Evidence Based Complementary and Alternative Medicine, 2006, 3, 49.

P. Vinas, M. Bravo-Bravo, I. Lopez-Garcia, M. Hernandez-Cordoba, Analytical Methods, 2012, 4, 2759.

R.G. Katare, A. Caporali, A. Oikawa, M. Meloni, C. Emanurli, P. Madeddu, Circulation Heart Failure, 2010, 3, 294.

J. DiNicolantonio, C.J. Lavie, A.K. Niazi, J.H. O’Keefe, T. Hu, Ochsner Journal, 2013, 13, 495.

R. Katare, A. Caporali, C Emanueli, P. Madeddu, Journal of Molecular and Cellular Cardiology, 2010, 49, 625.

H. Stracke, H.P. Hammes, D. Werkmann, K. Mavrakis, I. Bitsch, M. Netzel, Experimental and Clinical Endocrinology & Diabetes, 2001, 109, 330.

M.L. Volvert, S. Seven, M. Piette, B. Evrard, M. Gangolf, J.C. Plumier, BMC Pharmacology, 2008, 12, 8.

S. Hazell, S. Faim, G. Wertheimer, V. R. Silva, C. S. Marques, Neurochemistry International, 2013, 62, 796.

Stirban, M. Negrean, B. Stratmann, T. Gawlowski, T. Horstmann, C. Gotting, Diabetes Care, 2006, 29, 2064.

Nenna, F. Nappi, S.S. Avtaar Singh, F.W. Sutherland, F. Di Domenico, M. Chello, C. Spadaccio, Research in Cardiovascular Medicine, 2015, 23, 2.

Downloads

Published

2017-03-30

How to Cite

ILUȚIU-VARVARA, D.-A. ., RĂDULESCU, D. ., & DONCA, V. I. . (2017). BENFOTHIAMINE ADMINISTRATION IN PATIENTS WITH DILATED CARDIOMYOPATHY AND ADVANCED HEART FAILURE WITH CHRONIC DIURETIC TREATMENT. Studia Universitatis Babeș-Bolyai Chemia, 62(1), 229–236. https://doi.org/10.24193/subbchem.2017.1.20

Issue

Section

Articles

Similar Articles

1 2 3 4 5 6 7 8 9 10 > >> 

You may also start an advanced similarity search for this article.